UBS Group’s ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN USML Stock Holding History

UBS Group’s Portfolio USML Stock Details USML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.1M	Buy	+77,101	New	+$3.26M	﹤0.01%	4564
2025 Q2	–	Sell	-100	Closed	-$4.24K	–	10854
2025 Q1	$4.24K	Buy	100 +59	+144%	+$2.42K	﹤0.01%	9129
2024 Q4	$1.57K	Buy	41 +11	+37%	+$452	﹤0.01%	9203
2024 Q3	$1.23K	Buy	+30	New	+$1.15K	﹤0.01%	8683
2022 Q3	–	Sell	-88	Closed	-$2K	–	10958
2022 Q2	$2K	Buy	+88	New	+$2.59K	﹤0.01%	9626

Other funds holding USML

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

UBS Group's USML Position: Q1 2026 in Review

UBS Group opened a new position in ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN (USML) in Q1 2026: 77,101 shares worth $3.1M. The stake represents ﹤0.01% of the portfolio and ranks #4564 among its holdings. This is a return to the name: UBS Group previously reported a position in USML as recently as Q1 2025.

UBS Group first reported a position in USML in Q2 2022 and has held it in 5 quarters since. 2 funds tracked by Wall St. Rank hold USML as of Q1 2026.

UBS Group held 77,101 shares of ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN worth $3.1M as of Q1 2026.
ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN was a new UBS Group position in Q1 2026.
ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4564 holding.
UBS Group first reported a position in ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN in Q2 2022 and has held it in 5 quarters since.
2 funds tracked by Wall St. Rank held ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.